An Exploratory Study on the Treatment of Advanced Solid Tumors by Secretory PD1 Nanoantibody Targeting Mesothelin Fast CAR T Cells
Latest Information Update: 15 Feb 2024
At a glance
- Drugs BZT 2312 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Shanghai Cell Therapy Group
Most Recent Events
- 15 Feb 2024 New trial record